Pricing
  1. JP-listed companies
  2. AFC-HD AMS Life Science Co.,Ltd.
  3. Financials
  4. EBITDA margin (%)

AFC-HD AMS Life Science Co.,Ltd.【JP:2927】

Market cap
¥12.7B
P/E ratio
8.5x
AFC-HD Amus Life Science develops and sells health foods, cosmetics, and pharmaceuticals to consumers and medical institutions across multiple channels.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Aug 31, 202510.8+16.94%
Aug 31, 20249.2-4.29%
Aug 31, 20239.6+18.61%
Aug 31, 20228.1-36.51%
Aug 31, 202112.8+26.07%
Aug 31, 202010.1+13.24%
Aug 31, 20198.9-3.18%
Aug 31, 20189.2-3.67%
Aug 31, 20179.6+9.07%
Aug 31, 20168.8-8.32%
Aug 31, 20159.6+22.84%
Aug 31, 20147.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)